Taldefgrobep
Sources
registry, as of 2026-03-20Stale
https://clinicaltrials.gov/study/NCT07281495
Taldefgrobep Alfa in Adults With Overweight and Obesity. Overall status ACTIVE_NOT_RECRUITING. Phases PHASE2. Lead sponsor Biohaven Therapeutics Ltd.. Enrollment 150. Conditions Obesity; Overweight. This is a multicenter, randomized, double-blind, placebo-controlled, multiple dose study to evaluate the efficacy, safety, and tolerability of taldefgrobep alfa in adults with overweight and obesity, with an open-label extension.
ClinicalTrials.gov NCT07281495 protocol and results modules